Robin Kramer - Feb 10, 2025 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Accounting Officer
Signature
/s/ Samuel Ntonme, attorney-in-fact for Robin Kramer
Stock symbol
BIIB
Transactions as of
Feb 10, 2025
Transactions value $
-$34,922
Form type
4
Date filed
2/12/2025, 05:44 PM
Previous filing
Feb 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +834 +11.24% $0.00 8.26K Feb 10, 2025 Direct
transaction BIIB Common Stock Tax liability -$34.9K -245 -2.97% $142.54 8.01K Feb 10, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -834 -100% $0.00 0 Feb 10, 2025 Common Stock 834 $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.